Appeal No. 2007-0311 Application No. 10/175,744 SUMMARY Appellants have not disclosed a specific and substantial utility for the claimed antibodies. We therefore affirm the rejections of claims 25-29 under 35 U.S.C. §§ 101 and 112, first paragraph, for lack of patentable utility. No time period for taking any subsequent action in connection with this appeal may be extended under 37 CFR § 1.136(a)(1)(iv) (2004). AFFIRMED Eric Grimes ) Administrative Patent Judge ) ) ) ) BOARD OF PATENT Nancy J. Linck ) Administrative Patent Judge ) APPEALS AND ) ) INTERFERENCES ) Richard M. Lebovitz ) Administrative Patent Judge ) EG 7Page: Previous 1 2 3 4 5 6 7 8 Next
Last modified: September 9, 2013